ArticleNature nanotechnology2026

Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy.

Pei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.